Melanoma Management

eISSN: 2045-0893pISSN: 2045-0885
JournalOpen Access

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

SNIP
0.01
6
Time to Publish
time-to-publish View Chart
7  Mo

Journal Specifications

Overview
  • Publisher
    FUTURE MEDICINE LTD
  • Language
    English
  • Frequency
    Quarterly
  • Article Processing Charges
    USD 1415
  • Publication Time
    13
  • Editorial Review Process
    Double anonymous peer review
General Details
Publication Details
Editorial Review Detail
Information for authors
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

check-iconMeets Top Publisher Standards: Essential for leading journals like Elsevier.
check-iconEnhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
check-iconTailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn morethumb-icon 3000+ graphical abstracts produced with 4.8/5 customer rating
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 0%
4-6 44%
7-9 33%
>9 22%

Topics Covered

Stage melanoma
Dendritic cell vaccine
Cutaneous melanoma
Intracranial Melanoma
Systematic review

Recently Published Papers

Year-wise Publication

FAQs

Since when has Melanoma Management been publishing? Faqs

The Melanoma Management has been publishing since 2014 till date.

How frequently is the Melanoma Management published? Faqs

Melanoma Management is published Quarterly.

Who is the publisher of Melanoma Management? Faqs

The publisher of Melanoma Management is FUTURE MEDICINE LTD.

How can I view the journal metrics of Melanoma Management on editage? Faqs

For the Melanoma Management metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Melanoma Management? Faqs

The eISSN number is 2045-0893 and pISSN number is 2045-0885 for Melanoma Management.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Stage melanoma, Dendritic cell vaccine, Cutaneous melanoma, Intracranial Melanoma, Systematic review.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.